نتایج جستجو برای: thromboembolic event

تعداد نتایج: 210109  

2017
Naoki Shibata Itsuro Morishima Kenji Okumura Yasuhiro Morita Kensuke Takagi Ruka Yoshida Hiroaki Nagai Toshiro Tomomatsu Yoshihiro Ikai Kazushi Terada Kazuhito Tsuzuki Hideyuki Tsuboi Takahito Sone Toyoaki Murohara

BACKGROUND Anticoagulation therapy with the vitamin K antagonist (VKA) warfarin has been demonstrated to reduce thromboembolic risk after electrical cardioversion (ECV). However, data concerning ECV with non-VKA oral anticoagulants (NOACs) is limited. The objective of this study was to determine the efficacy and safety of NOACs in patients undergoing ECV in a real-world clinical practice at a s...

Journal: :Annals of the Academy of Medicine, Singapore 2000
L H Lee

INTRODUCTION This study evaluated the intensity of anticoagulation required for prevention of thromboembolic episodes with minimal haemorrhagic complications in patients with mechanical heart valve prostheses. MATERIALS AND METHODS The incidence of thrombotic and haemorrhagic events was retrospectively assessed in a series of 143 patients attending the anticoagulation clinic over a period of ...

Journal: :Anesthesiology 2003
Carlos B Mantilla Terese T Horlocker Darrell R Schroeder Daniel J Berry David L Brown

BACKGROUND Prevention of thromboembolic complications after elective lower extremity arthroplasty has increasingly relied on routine thromboprophylaxis in all patients. Not all patients are at equal risk, however, and prophylaxis is not devoid of complications. The aim of this study was to examine the risk factors for clinically relevant pulmonary embolism and deep venous thrombosis after elect...

Journal: :Cardiologia Hungarica (Nyomtatott) 2021

Heart failure patients may have impaired cerebral autoregulation and regional blood flow abnormalities. Predisposition to thromboembolic complications occur because of dilated chambers abnormal flow, vessel/chamber lining particles in heart patients. Epidemiological clinical studies document an increased rate failure. Well known/accepted indications oral anticoagulation therapy prevent events a...

Journal: :Annals of military and health sciences research 2023

Context: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as a novel virus infection, was first detected in China 2019 and has quickly spread pandemic leading to high mortality rate unprecedented challenges for healthcare systems. Although the SARS-CoV-2 clinical spectrum is different, failure of function coagulopathy common manifestation can be observed cases with severe disease (...

2007
Jack Copeland

In 1992, based on extensive review of the literature, we concluded that in patients with mechanical prosthetic heart valves,1 (1) long-term (permanent) therapy with oral anticoagulants offers the most consistent protection, and (2) levels of oral anticoagulants that prolong the prothrombin time (PT) ratio to an international normalized ratio (INR) of 2.5 to 3.5 are satisfactory for tilting disk...

Journal: :Circulation 2016
John E Cannon Li Su David G Kiely Kathleen Page Mark Toshner Emilia Swietlik Carmen Treacy Anie Ponnaberanam Robin Condliffe Karen Sheares Dolores Taboada John Dunning Steven Tsui Choo Ng Deepa Gopalan Nicholas Screaton Charlie Elliot Simon Gibbs Luke Howard Paul Corris James Lordan Martin Johnson Andrew Peacock Robert MacKenzie-Ross Benji Schreiber Gerry Coghlan Kostas Dimopoulos Stephen J Wort Sean Gaine Shahin Moledina David P Jenkins Joanna Pepke-Zaba

BACKGROUND Chronic thromboembolic pulmonary hypertension results from incomplete resolution of pulmonary emboli. Pulmonary endarterectomy (PEA) is potentially curative, but residual pulmonary hypertension following surgery is common and its impact on long-term outcome is poorly understood. We wanted to identify factors correlated with poor long-term outcome after surgery and specifically define...

Journal: :Stroke 2016
Tobias Pilgaard Ottosen Miriam Grijota Morten Lock Hansen Axel Brandes Dorte Damgaard Steen Elkjær Husted Søren Paaske Johnsen

BACKGROUND AND PURPOSE The effectiveness and safety of antithrombotic therapy (AT) among patients with a history of intracerebral hemorrhage remain uncertain. We therefore determined the prevalence of indication for AT among patients hospitalized with first-time intracerebral hemorrhage and examined the impact of subsequent AT use on the long-term clinical outcome. METHODS We performed a popu...

2016
A. Kaifie M. Kirschner D. Wolf C. Maintz M. Hänel N. Gattermann E. Gökkurt U. Platzbecker W. Hollburg J. R. Göthert S. Parmentier F. Lang R. Hansen S. Isfort K. Schmitt E. Jost H. Serve G. Ehninger W. E. Berdel T. H. Brümmendorf S. Koschmieder

BACKGROUND Patients with Ph-negative myeloproliferative neoplasms (MPN), such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are at increased risk for thrombosis/thromboembolism and major bleeding. Due to the morbidity and mortality of these events, antiplatelet and/or anticoagulant agents are commonly employed as primary and/or secondary prophylaxis...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید